Critical concepts in cost-effectiveness for cardiovascular specialists

Am Heart J. 2000 Dec;140(6 Suppl):S143-7. doi: 10.1067/mhj.2000.111610.
No abstract available

Publication types

  • Review

MeSH terms

  • Cardiology / economics*
  • Cost-Benefit Analysis
  • Fibrinolytic Agents / economics
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Myocardial Ischemia / drug therapy
  • Outcome Assessment, Health Care / economics*
  • Thrombolytic Therapy / economics

Substances

  • Fibrinolytic Agents